• About
  • Advertise
  • Careers
  • Contact
  • Cookie Policy (EU)
Sunday, June 4, 2023
  • Login
No Result
View All Result
NEWSLETTER
Tipperary Times - Tipperary News as it Happens
  • Local News
  • Community
  • Business
  • Farming
  • Politics
  • Education
  • Life Style
  • Jobs
  • Sport
  • Local News
  • Community
  • Business
  • Farming
  • Politics
  • Education
  • Life Style
  • Jobs
  • Sport
No Result
View All Result
Tipperary Times - Tipperary News as it Happens
No Result
View All Result
Home Business

Lowry Welcomes €37.8m Investment in Cardiovascular R&D by Clonmel Based Abbott

by Paddy Ryan
July 27, 2021
in Business, Featured, Health, Jobs, Politics
0
Lowry Welcomes €37.8m Investment in Cardiovascular R&D by Clonmel Based Abbott
0
SHARES
Share on FacebookShare on Twitter

Deputy Michael Lowry has welcomed the announcement by global healthcare company Abbott of substantial further investment in its cardiovascular Research and Development Centre based at its Vascular devices site in Clonmel. 

In an announcement today, the Company has confirmed that over the next three years, Abbott will invest €37.8 million in an R&D programme focusing on the discovery, innovation and development of a number of projects, including next generation drug eluting stents, as well as coronary and endovascular balloon technologies.

The continued major investment programme in its R&D centre in Clonmel, supported by the Irish Government through IDA Ireland, comes as Abbott celebrates 75 years in Ireland this year.  

Abbott is the world leader in drug-eluting stents. Both R&D and manufacturing of Abbott’s new vascular technologies to treat complex heart disease take place at its Clonmel site. 

Over 90,000 Irish people have heart disease and it is one of the most common causes of hospitalisation in people aged over 65 in Ireland.

The Irish R&D team spent three years developing the company’s market-leading stent, XIENCE Sierra, which is being used worldwide in patients who, because of the nature of their disease, might not previously have been suitable for minimally invasive surgery.  Abbott’s manufacturing plant in Clonmel manufactures its XIENCE family of stents, including XIENCE Sierra, for global use.

Abbott was one of the first US companies to establish operations in Ireland and is one of our largest med-tech employers, with six manufacturing sites and three corporate services operations throughout the country.  This announcement reflects Abbott’s ongoing commitment to Ireland. It is also a tribute to the management and staff of Abbott’s vascular division in Clonmel, who have played a pivotal role in the global success of Abbott’s XIENCE Sierra stent. 

‘This major investment by Abbot is a significant boost for Clonmel and for Tipperary as it underlines their ongoing commitment to the county into the future’ says Deputy Lowry.

Next Post
283 Residential Buildings Under Construction in Tipperary in June 2021

283 Residential Buildings Under Construction in Tipperary in June 2021

ADVERTISEMENT

Recommended

IMG 2895

Former Taro Pharmaceutical Site Up for Sale – A Positive Development for Roscrea Noel Coonan TD

7 years ago
History makers and record breakers on course for Punchestown Festival as Grade 1 entries revealed

History makers and record breakers on course for Punchestown Festival as Grade 1 entries revealed

2 years ago

Popular News

Plugin Install : Popular Post Widget need JNews - View Counter to be installed

Connect with us

About Us

Bringing Local News and updates to you.

Newsletter

Sign up for the Tipperary Times Daily Digest

© 2021 An AMV Publication - Agency Partner Trigger Media.

No Result
View All Result
  • Home
  • Community
  • Local News
  • Business
  • Tipperary Sport
  • Farming
  • Obituaries
  • Education
  • Entertainment
  • Health
  • Life Style
  • Opinion
  • Politics
  • Contact

© 2021 An AMV Publication - Agency Partner Trigger Media.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In